Richard M Bergenstal (Richard Bergenstal)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 79

Top Topics

Glycemic Control

Artificial Intelligence

Clinical Practice

Psychometric Properties

Top Venues

Diabetes technology & therapeutics

Journal of diabetes science and technology

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Irl B Hirsch, Christopher G Parkin, Tricia Santos Cavaiola, Richard M Bergenstal
Use of continuous glucose monitoring when initiating glucagon-like peptide-1 receptor agonist therapy in insulin-treated diabetes. Diabetes, obesity & metabolism (2024)
Bruce A Buckingham, Richard M Bergenstal
Decreasing the Burden of Carbohydrate Counting and Meal Announcement with Automated Insulin Delivery, Meal Recognition, and Autocorrection Doses: A Case Study. Diabetes technology & therapeutics 26 (S3) (2024)
Rodolfo J Galindo, Bobak Moazzami, Katherine R Tuttle, Richard M Bergenstal, Limin Peng, Guillermo E Umpierrez
Continuous Glucose Monitoring Metrics and Hemoglobin A1c Relationship in Patients with Type 2 Diabetes Treated by Hemodialysis. Diabetes technology & therapeutics (2024)
Jennifer L Sherr, Lori M B Laffel, Jingwen Liu, Wendy Wolf, Jeoffrey Bispham, Katherine S Chapman, Daniel Finan, Lina Titievsky, Tina Liu, Kaitlin Hagan, Jason Gaglia, Keval Chandarana, Richard M Bergenstal, Jeremy H Pettus
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey. Diabetes care 47 (6) (2024)
Richard M Bergenstal, Athena Philis-Tsimikas, Carol H Wysham, Molly C Carr, Juliana M Bue-Valleskey, Fady T Botros, Thomas Blevins, Julio Rosenstock
Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme. Diabetes, obesity & metabolism 26 (8) (2024)
Satish K Garg, Irl B Hirsch, Enrico Repetto, Janet Snell-Bergeon, Brian Ulmer, Christopher Perkins, Richard M Bergenstal
Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real-world analysis. Diabetes, obesity & metabolism (2024)
Jennifer L Sherr, Lori M B Laffel, Jingwen Liu, Wendy Wolf, Jeoffrey Bispham, Katherine S Chapman, Daniel Finan, Lina Titievsky, Tina Liu, Kaitlin Hagan, Jason Gaglia, Keval Chandarana, Richard M Bergenstal, Jeremy H Pettus
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey. Diabetes care 47 (6) (2024)
Jennifer L Sherr, Lori M B Laffel, Jingwen Liu, Wendy Wolf, Jeoffrey Bispham, Katherine S Chapman, Daniel Finan, Lina Titievsky, Tina Liu, Kaitlin Hagan, Jason Gaglia, Keval Chandarana, Richard M Bergenstal, Jeremy H Pettus
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey. Diabetes care 47 (6) (2024)
Bruce A Buckingham, Richard M Bergenstal
Decreasing the Burden of Carbohydrate Counting and Meal Announcement with Automated Insulin Delivery, Meal Recognition, and Autocorrection Doses: A Case Study. Diabetes technology & therapeutics 26 (S3) (2024)
Mark Warren, Richard M Bergenstal, Matthew Hager, Eran Bashan, Israel Hodish
A Scalable Application of Artificial Intelligence-Driven Insulin Titration Program to Transform Type 2 Diabetes Management. Diabetes technology & therapeutics 26 (8) (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy. Diabetes care 47 (4) (2024)
Anders L Carlson, Timothy E Graham, Halis Kaan Akturk, David R Liljenquist, Richard M Bergenstal, Becky Sulik, Viral N Shah, Mark Sulik, Peter Zhao, Peter Briggs, Ravid Sassan-Katchalski, Jordan E Pinsker
Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial. Journal of diabetes science and technology (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy. Diabetes care 47 (4) (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study): Differential Treatment Effects of Dual Therapy. Diabetes care (2024)
Richard M Bergenstal, Roy W Beck
The Glucose Management Indicator: Time to Change Course? Diabetes Care 2024;47:906-914. Diabetes care 47 (6) (2024)
Richard M Bergenstal, Athena Philis-Tsimikas, Carol H Wysham, Molly C Carr, Juliana M Bue-Valleskey, Fady T Botros, Thomas Blevins, Julio Rosenstock
Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme. Diabetes, obesity & metabolism (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy. Diabetes care 47 (4) (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study): Differential Treatment Effects of Dual Therapy. Diabetes care (2024)
Richard M Bergenstal, Roy W Beck
The Glucose Management Indicator: Time to Change Course? Diabetes Care 2024;47:906-914. Diabetes care 47 (6) (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy. Diabetes care 47 (4) (2024)
Jennifer E Layne, Lauren H Jepson, Alexander M Carite, Christopher G Parkin, Richard M Bergenstal
Long-Term Improvements in Glycemic Control with Dexcom CGM Use in Adults with Noninsulin-Treated Type 2 Diabetes. Diabetes technology & therapeutics (2024)
Mark Warren, Richard M Bergenstal, Matthew Hager, Eran Bashan, Israel Hodish
A Scalable Application of Artificial Intelligence-Driven Insulin Titration Program to Transform Type 2 Diabetes Management. Diabetes technology & therapeutics (2024)
Gregg D Simonson, Amy B Criego, Tadej Battelino, Anders L Carlson, Pratik Choudhary, Sylvia Franc, Dana Gershenoff, George Grunberger, Irl B Hirsch, Diana Isaacs, Mary L Johnson, David Kerr, Davida F Kruger, Chantal Mathieu, Thomas W Martens, Revital Nimri, Sean M Oser, Anne L Peters, Tracey D Brown, Eugene E Wright, Carol H Wysham, Richard M Bergenstal
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens. Diabetes technology & therapeutics (2024)
Yongjin Xu, Timothy C Dunn, Richard M Bergenstal, Alan Cheng, Yaghoub Dabiri, Ramzi A Ajjan
Time in Range, Time in Tight Range, and Average Glucose Relationships Are Modulated by Glycemic Variability: Identification of a Glucose Distribution Model Connecting Glycemic Parameters Using Real-World Data. Diabetes technology & therapeutics (2024)
Jennifer L Sherr, Lori M B Laffel, Jingwen Liu, Wendy Wolf, Jeoffrey Bispham, Katherine S Chapman, Daniel Finan, Lina Titievsky, Tina Liu, Kaitlin Hagan, Jason Gaglia, Keval Chandarana, Richard M Bergenstal, Jeremy H Pettus
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey. Diabetes care 47 (6) (2024)
Zoey Li, Roy W Beck, Celeste Durnwald, Anders Carlson, Elizabeth Norton, Richard M Bergenstal, Mary Johnson, Sean Dunnigan, Matthew Banfield, Katie Krumwiede, Judy Sibayan, Peter Calhoun
Continuous Glucose Monitoring Prediction of Gestational Diabetes Mellitus and Perinatal Complications. Diabetes technology & therapeutics (2024)
Jennifer L Sherr, Lori M B Laffel, Jingwen Liu, Wendy Wolf, Jeoffrey Bispham, Katherine S Chapman, Daniel Finan, Lina Titievsky, Tina Liu, Kaitlin Hagan, Jason Gaglia, Keval Chandarana, Richard M Bergenstal, Jeremy H Pettus
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-Sectional Survey. Diabetes care (2024)
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal, Joshua I Barzilay, Cyrus V Desouza, Ralph A De Fronzo, Tom Elasy, Jonathan Krakoff, Steven E Kahn, Neda Rasouli, Willy M Valencia, William I Sivitz, null null
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy. Diabetes care 47 (4) (2024)
Yongjin Xu, Timothy C Dunn, Richard M Bergenstal, Alan Cheng, Yaghoub Dabiri, Ramzi A Ajjan
Time in Range, Time in Tight Range, and Average Glucose Relationships Are Modulated by Glycemic Variability: Identification of a Glucose Distribution Model Connecting Glycemic Parameters Using Real-World Data. Diabetes technology & therapeutics 26 (7) (2024)
Timothy C Dunn, Ramzi A Ajjan, Richard M Bergenstal, Yongjin Xu
Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes. Diabetes technology & therapeutics 26 (3) (2024)
Jingtong Huang, Andrea M Yeung, Richard M Bergenstal, Kristin N Castorino, Eda Cengiz, Ketan K Dhatariya, Isabella Niu, Jennifer L Sherr, Guillermo E Umpierrez, David C Klonoff
Update on Measuring Ketones. Journal of diabetes science and technology (2023)
Roy W Beck, Dan Raghinaru, Peter Calhoun, Richard M Bergenstal
The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose Monitoring. Diabetes technology & therapeutics 25 (3) (2023)
Roy W Beck, Dan Raghinaru, Peter Calhoun, Richard M Bergenstal
A Comparison of Continuous Glucose Monitoring-Measured Time-in-Range 70-180 mg/dL Versus Time-in-Tight-Range 70-140 mg/dL. Diabetes technology & therapeutics (2023)
Timothy C Dunn, Yongjin Xu, Richard M Bergenstal, Wataru Ogawa, Ramzi A Ajjan
Personalized Glycated Hemoglobin in Diabetes Management: Closing the Gap with Glucose Management Indicator. Diabetes technology & therapeutics 25 (S3) (2023)
Naunihal Virdi, Yeesha Poon, Richard Abaniel, Richard M Bergenstal
Prevalence, Cost, and Burden of Diabetic Ketoacidosis. Diabetes technology & therapeutics 25 (S3) (2023)
Francesco Giorgino, Tadej Battelino, Richard M Bergenstal, Thomas Forst, Jennifer B Green, Chantal Mathieu, Helena W Rodbard, Oliver Schnell, Emma G Wilmot
The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus. Journal of diabetes science and technology (2023)
Othmar Moser, James Rafferty, Max L Eckstein, Faisal Aziz, Stephen C Bain, Richard M Bergenstal, Harald Sourij, Rebecca L Thomas
Impact of severe hypoglycaemia requiring hospitalization on mortality in people with type 1 diabetes: A national retrospective observational cohort study. Diabetes, obesity & metabolism (2023)
Roy W Beck, Dan Raghinaru, Peter Calhoun, Richard M Bergenstal
The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose Monitoring. Diabetes technology & therapeutics (2023)
Richard M Bergenstal, Bruce W Bode, Anuj Bhargava, Qianqian Wang, Alastair W Knights, Annette M Chang
Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Richard M Bergenstal
Roadmaps to Continuous Glucose Monitoring's Role in Transforming Diabetes Management. Diabetes spectrum : a publication of the American Diabetes Association 36 (4) (2023)
Viral N Shah, Timothy Vigers, Laura Pyle, Peter Calhoun, Richard M Bergenstal
Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes. Diabetes technology & therapeutics (2023)
Ronald M Goldenberg, Vanita R Aroda, Liana K Billings, Anders Meller Donatsky, Marie Frederiksen, David C Klonoff, Balamurali Kalyanam, Richard M Bergenstal
Correlation Between Time in Range and HbA1c in People with Type 2 Diabetes on Basal Insulin: Post Hoc Analysis of the SWITCH PRO Study. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Richard M Bergenstal
Roadmap to the Effective Use of Continuous Glucose Monitoring: Innovation, Investigation, and Implementation. Diabetes spectrum : a publication of the American Diabetes Association 36 (4) (2023)
Roy W Beck, Dan Raghinaru, Peter Calhoun, Richard M Bergenstal
The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose Monitoring. Diabetes technology & therapeutics 25 (3) (2023)
Roy W Beck, Dan Raghinaru, Peter Calhoun, Richard M Bergenstal
The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose Monitoring. Diabetes technology & therapeutics 25 (3) (2023)
Dan Raghinaru, Peter Calhoun, Richard M Bergenstal, Roy W Beck
The Optimal Duration of a Run-In Period to Initiate Continuous Glucose Monitoring for a Randomized Trial. Diabetes technology & therapeutics 24 (12) (2022)
Klemen Dovc, Tadej Battelino, Roy W Beck, Judy Sibayan, Ryan J Bailey, Peter Calhoun, Christine Turcotte, Stuart A Weinzimer, Darja Smigoc Schweiger, Richard M Bergenstal
Impact of Temporary Glycemic Target Use in the Hybrid and Advanced Hybrid Closed-Loop Systems. Diabetes technology & therapeutics 24 (11) (2022)
Jennifer L Sherr, Lutz Heinemann, G Alexander Fleming, Richard M Bergenstal, Daniela Bruttomesso, Hélène Hanaire, Reinhard W Holl, John R Petrie, Anne L Peters, Mark Evans
Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetologia 66 (1) (2022)
Tadej Battelino, Thomas Danne, Steve V Edelman, Pratik Choudhary, Pr Eric Renard, Jukka Westerbacka, Bhaswati Mukherjee, Valerie Pilorget, Mathieu Coudert, Richard M Bergenstal
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial. Diabetes, obesity & metabolism (2022)
Jennifer L Sherr, Lutz Heinemann, G Alexander Fleming, Richard M Bergenstal, Daniela Bruttomesso, Hélène Hanaire, Reinhard W Holl, John R Petrie, Anne L Peters, Mark Evans
Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetes care 45 (12) (2022)
Moshe Phillip, Revital Nimri, Richard M Bergenstal, Katharine D Barnard-Kelly, Thomas Danne, Roman Hovorka, Boris P Kovatchev, Laurel H Messer, Christopher G Parkin, Louise Ambler-Osborn, Stephanie A Amiel, Lia Bally, Roy W Beck, Sarah Biester, Torben Biester, Julia E Blanchette, Emanuele Bosi, Charlotte K Boughton, Marc D Breton, Sue A Brown, Bruce A Buckingham, Albert Cai, Anders L Carlson, Jessica R Castle, Pratik Choudhary, Kelly L Close, Claudio Cobelli, Amy B Criego, Elizabeth A Davis, Carine de Beaufort, Martin I de Bock, Daniel J DeSalvo, J Hans DeVries, Klemen Dovc, Francis J Doyle, Laya Ekhlaspour, Naama Fisch Shvalb, Gregory P Forlenza, Geraldine Gallen, Satish K Garg, Dana C Gershenoff, Linda A Gonder-Frederick, Ahmad Haidar, Sara Hartnell, Lutz Heinemann, Simon Heller, Irl B Hirsch, Korey K Hood, Diana Isaacs, David C Klonoff, Olga Kordonouri, Aaron Kowalski, Lori M B Laffel, Julia Lawton, Rayhan A Lal, Lalantha Leelarathna, David M Maahs, Helen R Murphy, Kirsten Nørgaard, David O'Neal, Sean M Oser, Tamara K Oser, Pr Eric Renard, Michael C Riddell, David Rodbard, Steven J Russell, Desmond A Schatz, Viral N Shah, Jennifer L Sherr, Gregg D Simonson, R Paul Wadwa, Candice Ward, Stuart A Weinzimer, Emma G Wilmot, Tadej Battelino
Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice. Endocrine reviews (2022)
Ryan Bailey, Peter Calhoun, Roy W Beck, Richard M Bergenstal, Grazia Aleppo
Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737. Diabetes care 45 (4) (2022)
Yongjin Xu, Richard M Bergenstal, Timothy C Dunn, Yashesvini Ram, Ramzi A Ajjan
Interindividual variability in average glucose-glycated haemoglobin relationship in type 1 diabetes and implications for clinical practice. Diabetes, obesity & metabolism 24 (9) (2022)
Ryan J Bailey, Peter Calhoun, Richard M Bergenstal, Roy W Beck
Assessment of the Glucose Management Indicator Using Different Sampling Durations. Diabetes technology & therapeutics (2022)
Harpreet S Bajaj, Richard M Bergenstal, Andreas Christoffersen, Melanie J Davies, Amoolya Gowda, Joakim Isendahl, Ildiko Lingvay, Peter A Senior, Robert J Silver, Roberto Trevisan, Julio Rosenstock
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial. Diabetes care 44 (7) (2021)
Othmar Moser, Michael C Riddell, Max L Eckstein, Peter Adolfsson, Remi Rabasa-Lhoret, Louisa van den Boom, Pieter Gillard, Kirsten Nørgaard, Nicholas S Oliver, Dessi P Zaharieva, Tadej Battelino, Carine de Beaufort, Richard M Bergenstal, Bruce A Buckingham, Eda Cengiz, Asma Deeb, Tim Heise, Simon R Heller, Aaron J Kowalski, Lalantha Leelarathna, Chantal Mathieu, Christoph Stettler, Martin Tauschmann, Hood Thabit, Emma G Wilmot, Harald Sourij, Carmel E M Smart, Peter G Jacobs, Richard M Bracken, Julia Katharina Mader
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). Diabetologia 63 (12) (2021)
Tadej Battelino, Richard M Bergenstal
Continuous Glucose Monitoring-Derived Data Report-Simply a Better Management Tool. Diabetes care 43 (10) (2021)
Thomas W Martens, Janet S Lima, Elizabeth A Johnson, Jessica A Conry, Jennifer J Hoppe, Richard M Bergenstal, Anders L Carlson, Janet L Davidson
Trial of a New Diabetes Education Model: Closing the Gap in Health Disparity for People with Diabetes. Journal of diabetes science and technology 15 (3) (2021)
Kevin T Nguyen, Nicole Y Xu, Jennifer Y Zhang, Trisha Shang, Ananda Basu, Richard M Bergenstal, Kristin N Castorino, Kong Y Chen, David C Klonoff, Suneil K Koliwad, Lori M B Laffel, Nestoras Nicolas Mathioudakis, L Kurt Midyett, Joshua D Miller, James H Nichols, Francisco J Pasquel, Priya Prahalad, Mark R Prausnitz, Jane Jefferie Seley, Jennifer L Sherr, Elias K Spanakis, Guillermo E Umpierrez, Amisha Wallia, David C Klonoff
Continuous Ketone Monitoring Consensus Report 2021. Journal of diabetes science and technology (2021)
Gregg D Simonson, Richard M Bergenstal, Mary L Johnson, Janet L Davidson, Thomas W Martens
Effect of Professional CGM (pCGM) on Glucose Management in Type 2 Diabetes Patients in Primary Care. Journal of diabetes science and technology 15 (3) (2021)
Richard M Bergenstal, Matthew S D Kerr, Gregory J Roberts, Diana Souto, Yelena Nabutovsky, Irl B Hirsch
Flash CGM Is Associated With Reduced Diabetes Events and Hospitalizations in Insulin-Treated Type 2 Diabetes. Journal of the Endocrine Society 5 (4) (2021)
Sue A Brown, Gregory P Forlenza, Bruce W Bode, Jordan E Pinsker, Carol J Levy, Amy B Criego, David W Hansen, Irl B Hirsch, Anders L Carlson, Richard M Bergenstal, Jennifer L Sherr, Sanjeev N Mehta, Lori M B Laffel, Viral N Shah, Anuj Bhargava, Tracey D Brown, Sarah A MacLeish, Daniel J DeSalvo, Thomas C Jones, Grazia Aleppo, Bruce A Buckingham, Trang T Ly, null null
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes. Diabetes care 44 (7) (2021)
Richard M Bergenstal, Gregg D Simonson, Lutz Heinemann
More Green, Less Red: How Color Standardization May Facilitate Effective Use of CGM Data. Journal of diabetes science and technology (2021)
Roy W Beck, Richard M Bergenstal
Beyond A1C-Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve. Diabetes spectrum : a publication of the American Diabetes Association 34 (2) (2021)
Othmar Moser, Michael C Riddell, Max L Eckstein, Peter Adolfsson, Remi Rabasa-Lhoret, Louisa van den Boom, Pieter Gillard, Kirsten Nørgaard, Nicholas S Oliver, Dessi P Zaharieva, Tadej Battelino, Carine de Beaufort, Richard M Bergenstal, Bruce A Buckingham, Eda Cengiz, Asma Deeb, Tim Heise, Simon R Heller, Aaron J Kowalski, Lalantha Leelarathna, Chantal Mathieu, Christoph Stettler, Martin Tauschmann, Hood Thabit, Emma G Wilmot, Harald Sourij, Carmel E M Smart, Peter G Jacobs, Richard M Bracken, Julia Katharina Mader
Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter]. Diabetologia 64 (4) (2021)
Richard M Bergenstal, Mary L Johnson, Vanita R Aroda, Ronald L Brazg, Darlene M Dreon, Juan P Frias, Davida F Kruger, Mark E Molitch, Deborah M Mullen, Mark Peyrot, Sara Richter, Julio Rosenstock, Pierre Serusclat, Carl Vance, Tracey D Brown, Brian L Levy
Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles. Journal of diabetes science and technology (2021)
Janet L Davidson, Richard M Bergenstal, Jessica A Conry, Ruth Taswell, Anders L Carlson
Initiating Insulin in the Emergency Center and Urgent Care to Prevent Hospital Admission for Patients with Hyperglycemia: A Unique Insulin Starter Kit. Journal of diabetes science and technology 15 (4) (2021)
Robin L Gal, Nathan J Cohen, Davida Kruger, Roy W Beck, Richard M Bergenstal, Peter Calhoun, Terra Cushman, Amanda Haban, Korey K Hood, Mary L Johnson, Teresa McArthur, Beth A Olson, Tracey D Brown, Sean M Oser, Tamara K Oser, Brian Bugielski, Heidi Strayer, Grazia Aleppo
Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring. Journal of the Endocrine Society 4 (9) (2020)
Lalantha Leelarathna, Hood Thabit, Malgorzata E Willinska, Lia Bally, Julia Katharina Mader, Sabine Arnolds, Carsten Benesch, Thomas R Pieber, Viral N Shah, Anders L Carlson, Richard M Bergenstal, Mark L Evans, Roman Hovorka, null null
Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes care 43 (3) (2020)
Thomas W Martens, Richard M Bergenstal, Teresa Pearson, Anders L Carlson, Gary Scheiner, Campos Carlos, Birong Liao, Kristen Syring, Roy Daniel Pollom
Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C). Postgraduate medicine 133 (3) (2020)
Janet L Davidson, Mary L Johnson, Gregg D Simonson, Amy B Criego, Thomas W Martens, Anders L Carlson, Richard M Bergenstal
International Diabetes Center: COVID-19 Won't Stop Us From Fulfilling Our Mission. Journal of diabetes science and technology 14 (4) (2020)
G Alexander Fleming, John R Petrie, Richard M Bergenstal, Reinhard W Holl, Anne L Peters, Lutz Heinemann
Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetes care 43 (1) (2019)
Lalantha Leelarathna, Roy W Beck, Richard M Bergenstal, Hood Thabit, Roman Hovorka, null null
Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor Data. Diabetes care 42 (4) (2019)
Tadej Battelino, Thomas P A Danne, Richard M Bergenstal, Stephanie A Amiel, Roy W Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close, Claudio Cobelli, Eyal Dassau, J Hans DeVries, Kim C Donaghue, Klemen Dovc, Francis J Doyle Iii, Satish Garg, George Grunberger, Simon R Heller, Lutz Heinemann, Irl B Hirsch, Roman Hovorka, Weiping Jia, Olga Kordonouri, Boris P Kovatchev, Aaron J Kowalski, Lori M B Laffel, Brian Levine, Alexander Mayorov, Chantal Mathieu, Helen R Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G Parkin, Pr Eric Renard, David Rodbard, Banshi Saboo, Desmond A Schatz, Keaton Stoner, Tatsuhiko Urakami, Stuart A Weinzimer, Moshe Phillip
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes care 42 (8) (2019)
Klemen Dovc, Charlotte Boughton, Martin Tauschmann, Hood Thabit, Lia Bally, Janet M Allen, Carlo L Acerini, Sabine Arnolds, Carine de Beaufort, Richard M Bergenstal, Fiona M Campbell, Amy Criego, Professor David Dunger, Daniella Elleri, Mark L Evans, Elke Fröhlich-Reiterer, Sabine Hofer, Thomas Kapellen, Lalantha Leelarathna, Thomas R Pieber, Birgit Rami-Merhar, Viral N Shah, Judy Sibayan, Malgorzata E Wilinska, Roman Hovorka, null null
Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery. Diabetes care 42 (7) (2019)
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes care 42 (3) (2018)
Yogish C Kudva, Andrew J Ahmann, Richard M Bergenstal, James R Gavin, Davida F Kruger, L Kurt Midyett, Eden Miller, Dennis R Harris
Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults. Journal of the Endocrine Society 2 (12) (2018)
Richard M Bergenstal, Roy W Beck, Kelly L Close, George Grunberger, David B Sacks, Aaron J Kowalski, Adam S Brown, Lutz Heinemann, Grazia Aleppo, Donna B Ryan, Tonya D Riddlesworth, William T Cefalu
Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes care 41 (11) (2018)
Richard M Bergenstal, Roy W Beck, Kelly L Close, George Grunberger, David B Sacks, Aaron J Kowalski, Adam S Brown, Lutz Heinemann, Grazia Aleppo, Donna B Ryan, Tonya D Riddlesworth, William T Cefalu
Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275-2280. Diabetes care 42 (2) (2018)